3型黄斑新生血管起始时视网膜色素上皮下多层高反射的解读
该回顾性研究分析了162只未治疗3型黄斑新生血管(MNV)眼,其中19眼在起始或临床检出时存在视网膜色素上皮下(sub-RPE)多层高反射,估计患病率为11.7%(95%CI 5.8-15.2)。随访1年,该组最佳矫正视力(BCVA)无改善(P=0.45),而对照组显著提高(P<0.001),提示该征象可能是视力预后不良的预测因素。
要点
- 3型MNV起始时sub-RPE多层高反射估计患病率为11.7%(95%CI 5.8-15.2)。
- 伴该征象眼1年BCVA无改善(P=0.45),对照组显著提高(P<0.001)。
- 该征象与退行性钙化玻璃膜疣及单眼多发3型病灶显著相关(均P<0.001)。
核心结论
- 3型MNV起始或临床检出时的sub-RPE多层高反射可能提示sub-RPE空间慢性渗出(即「洋葱征」)先于3型MNV出现,并可能是视力预后不良的重要预测因素。
研究设计与样本
- 回顾性分析连续诊断为继发于渗出性年龄相关性黄斑变性的3型MNV患者。
- 纳入19只未治疗眼在3型MNV起始时结构OCT显示sub-RPE多层高反射,来自162只未治疗3型MNV眼队列。
- 对照组为年龄、性别和分期匹配的143只无sub-RPE多层高反射的3型MNV眼。
- 分析两组患病率及抗VEGF注射后1年随访的治疗结局。
主要发现
- 19例患者(8男/11女,平均年龄83±8岁)共19只未治疗眼在3型MNV起始前或起始/临床检出时存在sub-RPE多层高反射。
- 估计患病率为11.7%(95%CI 5.8-15.2)。
- 病例组与对照组在年龄、性别、基线BCVA和注射次数上无显著差异。
- 伴sub-RPE多层高反射眼1年随访BCVA无改善(P=0.45),对照组BCVA显著提高(P<0.001)。
- sub-RPE多层高反射与退行性钙化玻璃膜疣(P<0.001)及单眼多发3型病灶(P<0.001)显著相关。
关键数值与推荐
- sub-RPE多层高反射在未治疗3型MNV眼中估计患病率为11.7%(95%CI 5.8-15.2)。
- 伴该征象眼1年BCVA无改善(P=0.45),对照组显著提高(P<0.001)。
- 该征象与退行性钙化玻璃膜疣及单眼多发3型病灶相关(均P<0.001)。
临床怎么用
- 在3型MNV起始或临床检出时识别sub-RPE多层高反射,可帮助预判抗VEGF治疗后视力改善有限。
- 对该征象眼应加强随访和预后沟通,避免对视力恢复抱过高预期。
局限性
- 回顾性设计,样本量有限(19只伴该征象眼)。
- 仅分析1年随访结局,缺乏更长期数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To report the prevalence and treatment outcomes of eyes with sub-retinal pigment epithelium (sub-RPE) multilaminar hyperreflectivity at the onset/clinical detection of Type 3 macular neovascularization (MNV) secondary to exudative age-related macular degeneration. METHODS: Retrospective analysis of consecutive patients diagnosed with Type 3 MNV secondary to age-related macular degeneration was performed. Eyes presenting with sub-RPE multilaminar hyperreflectivity on structural optical coherence tomography at the onset of Type 3 MNV were included in this study. An age-, sex-, and stage-matched control group was composed of eyes affected by Type 3 MNV without sub-RPE multilaminar hyperreflectivity. Prevalence and treatment outcomes after anti-vascular endothelial growth factor injections at 1-year follow-up were analyzed in both groups. RESULTS: Nineteen treatment-naïve eyes of 19 patients (8 men/11 women, mean age 83 ± 8 years old) presenting with sub-RPE multilaminar hyperreflectivity before or at the onset/clinical detection of Type 3 MNV were included from a cohort of 162 eyes with treatment-naïve Type 3 MNV. This accounts for an estimated prevalence of 11.7% (5.8-15.2, 95% confidence intervals). No significant differences were disclosed between cases studied and the control group (143 eyes of 143 patients) in age, sex, best-corrected visual acuity at baseline, and number of injections. Best-corrected visual acuity did not improve during the 1-year follow-up in patients showing sub-RPE multilaminar hyperreflectivity (P = 0.45), whereas best-corrected visual acuity significantly increased in the control group (P < 0.001). The presence of sub-RPE multilaminar hyperreflectivity in the context of Type 3 MNV was significantly associated with regressive calcific drusen (P < 0.001) and multiple Type 3 lesions/eye (P < 0.001). CONCLUSION: The detection of multilaminar hyperreflectivity at the onset/clinical detection of Type 3 MNV suggests that chronic exudation (i.e., the "onion-sign") in the sub-RPE space (i.e., focal sub-RPE neovascularization) may precede the onset/clinical detection of Type 3 MNV. Sub-retinal pigment epithelium multilaminar hyperreflectivity at the onset of Type 3 MNV may be an important predictor of poor visual outcome in these eyes.
引用
- Miere A, Sacconi R, Amoroso F, et al. SUB-RETINAL PIGMENT EPITHELIUM MULTILAMINAR HYPERREFLECTIVITY AT THE ONSET OF TYPE 3 MACULAR NEOVASCULARIZATION. Retina. 2021. PMID: 32282662. doi:10.1097/IAE.0000000000002815
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。